Compound: Modified GRF 1-29 (CJC-1295 without Drug Affinity Complex) Concentration: 5mg per vial Format: Lyophilized White Powder (Strictly for In-Vitro Laboratory Use) Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Syr-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Sark-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-L-Ser-Arg-NH2 Chemical Classification: Growth Hormone Releasing Hormone (GHRH) Analog Chemical Profile: CJC-1295 (No Dac), frequently referred to in literature as Mod GRF 1-29 , is a tetrasubstituted analogue of the endogenous Growth Hormone Releasing Hormone (GHRH)
Application Apply directly to the scalp, not the hair shaft
Optional ice: Apply cold pack to injection site for 30 to 60 seconds if you are prone to reactions Pinch: If lean, pinch a fold of skin at the injection site Insert: Quick, dart-like insertion at 90 degrees Inject: Slow, steady depression of plunger or pen button
Sosenko, J
200 In a randomized controlled trial published after the meta-analysis, a total of 171 patients with sudden sensorineural hearing loss were enrolled to receive HBOT, oral steroids, or a combination of both therapies
For more information, please contact Laura Mehegan at [email protected]
